Evidence map›Paper›PMID 41634063›Full record

ArticleScientific reports2026

Impact of hydrotalcite phases on the texture characteristic of OPC and its correlation with compressive strength and gamma Attenuation.

M Ramadan, M S Amin, Alaa Mohsen

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

M RamadanChemistry Department, Faculty of Science, Ain Shams University, Cairo, Egypt.
M S AminChemistry Department, Faculty of Science, Ain Shams University, Cairo, Egypt.
Alaa MohsenFaculty of Engineering, Ain Shams University, Cairo, Egypt. alaa.mohsen@eng.asu.edu.eg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hydrotalcites (HTs), recognized for their eco-friendly synthesis, layered structure, and exceptional ion-exchange capacity, offer significant potential as functional additives in cementitious systems. Most previous studies used different types of HT based on varying the kinds of di- or tri-valent cations during the preparation process, but they did not change the ratio between them. Accordingly, this study tailored three Mg-Al-CO₃-based HTs with varying Mg: Al ratios (1:1, 2:1, and 3:1, designated HT1, HT2, and HT3) and incorporated them at 1 wt% into ordinary Portland cement (OPC) pastes. The effects of HTs on setting time, workability, and compressive strength were evaluated. Phase composition, textural properties, and microstructure of reference and HT-modified pastes were characterized using XRD, BET/BJH analyses, and SEM/EDX. Additionally, gamma-ray shielding performance against Cs-137 (661.64 keV) was assessed by determining the linear attenuation coefficient (µ) and half-value layer (HVL). Results reveal that HTs accelerate setting, slightly reduce workability, enhance compressive strength, and significantly improve radiation shielding. Among the tailored HTs, HT1 exhibited superior performance, achieving the highest compressive strength (88.8 MPa at 28 days) and greatest shielding efficiency, with µ increased by 112.5% and HVL reduced by 52.9% compared to OPC. These improvements are attributed to HT1's high surface area, amorphous/mesoporous nature, and its role as a nucleation site and filler, leading to a dense microstructure. Furthermore, incorporating HTs provides an environmentally sustainable approach for producing high-performance cementitious materials with enhanced mechanical and radiological properties, supporting industrial applications in construction and nuclear safety.

Indexed as

Compressive strengthFresh propertiesHydrotalciteRadiation shieldingTexture parameters

Identifiers

PMID41634063
PMCPMC12873416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.